Alamar Biosciences, Inc. (ALMR)
Nasdaq · Laboratory Analytical Instruments · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Alamar Biosciences, Inc.. Most notable: 2026-09-01: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider buying cluster3 insiders bought $16.0M within 14 days
- Insider purchaseIllumina Innovation Fund II GP, L.L.C. (ten_percent_owner) bought $4.0M of stock
- Insider purchaseNaclerio Nicholas (director) bought $4.0M of stock
- Insider purchaseNaclerio Nicholas (director) bought $4.0M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-14 | Brottem John L. | officer | A | 29,000 | 0 | $0 |
| 2026-09-01 | RAGUSA ROBERT P | director | A | 5,686 | 0 | $0 |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | C | 185,163 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | J | 1,922,329 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | J | 1,605,645 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | J | 6,881,410 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | J | 185,163 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | C | 6,881,410 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | C | 1,605,645 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | C | 1,922,329 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | J | 185,163 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | J | 6,881,410 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | J | 1,605,645 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | ten percent owner | J | 1,922,329 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | ten percent owner | C | 346,020 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | ten percent owner | J | 5,510,516 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | ten percent owner | C | 4,588,364 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | ten percent owner | C | 922,152 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | ten percent owner | J | 5,510,516 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | ten percent owner | C | 271,782 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | ten percent owner | P | 235,294 | 17 | $3,999,998 |
| 2026-04-20 | White Timothy Ogden | officer | J | 454,583 | — | — |
| 2026-04-20 | White Timothy Ogden | officer | J | 454,583 | — | — |
| 2026-04-20 | White Timothy Ogden | officer | A | 37,220 | 0 | $0 |
| 2026-04-20 | Chen Shiping | director | A | 37,220 | 0 | $0 |
| 2026-04-20 | Chen Shiping | director | J | 722,885 | 0 | $0 |
| 2026-04-20 | Chen Shiping | director | J | 722,885 | — | — |
| 2026-04-20 | Chen Shiping | director | C | 320,511 | — | — |
| 2026-04-20 | Chen Shiping | director | C | 72,853 | — | — |
| 2026-04-20 | Luo Yuling | director | C | 364,268 | — | — |
| 2026-04-20 | Luo Yuling | director | J | 1,864,065 | — | — |
| 2026-04-20 | Luo Yuling | director | A | 76,509 | 0 | $0 |
| 2026-04-20 | Luo Yuling | director | J | 1,224,152 | — | — |
| 2026-04-20 | Luo Yuling | director | J | 1,224,152 | — | — |
| 2026-04-20 | Luo Yuling | director | J | 1,864,065 | — | — |
| 2026-04-20 | Luo Yuling | director | C | 1,386,746 | — | — |
| 2026-04-20 | Luo Yuling | director | C | 1,224,152 | — | — |
| 2026-04-20 | McAnear Justin J. | officer | A | 37,220 | 0 | $0 |
| 2026-04-20 | Naclerio Nicholas | director | P | 235,294 | 17 | $3,999,998 |
| 2026-04-20 | Naclerio Nicholas | director | C | 271,782 | — | — |
| 2026-04-20 | Naclerio Nicholas | director | C | 346,020 | — | — |
| 2026-04-20 | Naclerio Nicholas | director | J | 5,510,516 | — | — |
| 2026-04-20 | Naclerio Nicholas | director | C | 922,152 | — | — |
| 2026-04-20 | Naclerio Nicholas | director | C | 4,588,364 | — | — |
| 2026-04-20 | Naclerio Nicholas | director | J | 5,510,516 | — | — |
| 2026-04-20 | Naclerio Nicholas | director | A | 5,686 | 0 | $0 |
| 2026-04-20 | Qiming Corporate GP VI, Ltd.; Qiming Managing Directors Fund VI, L.P.; Qiming Venture Partners VI, L.P.; Qiming GP VIII, LLC; Qiming Venture Partners VIII Investments, LLC; Qiming GP VIII-HC, LLC; Qiming Venture Partners VIII-HC, L.P. | ten percent owner | C | 185,163 | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd.; Qiming Managing Directors Fund VI, L.P.; Qiming Venture Partners VI, L.P.; Qiming GP VIII, LLC; Qiming Venture Partners VIII Investments, LLC; Qiming GP VIII-HC, LLC; Qiming Venture Partners VIII-HC, L.P. | ten percent owner | C | 6,881,410 | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd.; Qiming Managing Directors Fund VI, L.P.; Qiming Venture Partners VI, L.P.; Qiming GP VIII, LLC; Qiming Venture Partners VIII Investments, LLC; Qiming GP VIII-HC, LLC; Qiming Venture Partners VIII-HC, L.P. | ten percent owner | C | 1,605,645 | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd.; Qiming Managing Directors Fund VI, L.P.; Qiming Venture Partners VI, L.P.; Qiming GP VIII, LLC; Qiming Venture Partners VIII Investments, LLC; Qiming GP VIII-HC, LLC; Qiming Venture Partners VIII-HC, L.P. | ten percent owner | C | 1,922,329 | — | — |
Federal contracts
24-month federal obligations: $197,070
- 2026-09-18 $99,990 · Department of Health and Human Services · NULISASEQ NEURO 220 PANEL. MULTIPLEXED PRECISION PROTEOMICS IMMUNOASSAY PANEL FOR NEUROLOGICAL DISEASE BIOMARKERS AND BU
- 2026-09-17 $57,080 · Department of Health and Human Services · ALAMAR BIOSCIENCES, INC.:1334504 [26-010199]
- 2026-09-21 $40,000 · Department of Health and Human Services · NIMH: SERVICE: NULISASEQ INFLAMMATION PANEL ASSAY SERVICE: SEVERABLE
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-16 3
- 2026-09-16 4
- 2026-09-03 4
- 2026-09-03 3
- 2026-09-01 8-K
- 2026-08-13 SCHEDULE 13G
- 2026-08-11 SCHEDULE 13G
- 2026-08-11 10-Q
- 2026-08-10 8-K
- 2026-07-15 8-K
- 2026-07-07 SCHEDULE 13D/A
- 2026-07-02 SCHEDULE 13G
- 2026-05-08 10-Q
- 2026-05-08 8-K
- 2026-04-23 SCHEDULE 13D
- 2026-04-23 SCHEDULE 13D
- 2026-04-22 4
- 2026-04-20 EFFECT
- 2026-04-20 4
- 2026-04-20 4